Rheumatology
From the Journals
Ultrasound’s value for arthralgia may be to rule out IA
Ultrasound’s ability to predict the development of inflammatory arthritis was low.
Conference Coverage
Incidental hip CT scans could serve as osteoporosis screen
DENVER – Bone mineral density and femoral strength calculated from CT scans that had been taken for another purpose performed better than did DXA...
From the Journals
Lack of lupus ‘gold standard’ definition hampers estimates of its incidence, prevalence
Two population-based registries attempt to determine the incidence and prevalence of the disease in the United States.
From the Journals
CREST syndrome and PBC are often associated
Sjögren’s syndrome and autoimmune thyroiditis are the most common extrahepatic autoimmune disorders associated with primary biliary cholangitis,...
Feature
Worsening osteoporosis care for RA patients shows need for action
Appropriate osteoporosis care in patients with rheumatoid arthritis is suboptimal and has been declining steadily over the past decade, but new...
Guidelines
New recommendations tout biosimilars for rheumatologic diseases
An international multidisciplinary task force came up with five overarching principles for the use of biosimilars and eight specific...
From the Journals
Vaccinate and consider tofacitinib monotherapy to prevent herpes zoster in RA
Two studies offer the best evidence yet in how to use zoster vaccination prior to starting tofacitinib and how to reduce risk of the infection...
From the Journals
Allopurinol extension trial backs treat-to-target approach in gout
The results alleviate fears of adverse events from heightened doses, especially in patients with impaired kidney function.
Conference Coverage
VIDEO: Prescription-strength ibuprofen worsens blood pressure more than other NSAIDs
BARCELONA – Celecoxib performs best in PRECISION-ABPM trial.
News
FDA approves second adalimumab biosimilar for multiple conditions
The biosimilar, called Cyltezo (adalimumab-adbm), is approved for all the same indications as Humira.
News
FDA approves once-daily treatment for hyperuricemia in gout
Duzallo is a fixed-dose combination of lesinurad 200 mg and allopurinol 300 mg and will also be available as lesinurad 200 mg plus allopurinol 200...